As Valeant’s Troubles Mount, Its Stock Price Takes Another Dive
The drug company denies a report that it artificially-inflated revenue.
Read more on NPR
http://ift.tt/1LomWQP
As Valeant’s Troubles Mount, Its Stock Price Takes Another Dive
The drug company denies a report that it artificially-inflated revenue.
Read more on NPR
No comments:
Post a Comment